welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!

Duchenne Awareness UK WDAD Interview With Duchenne UK’s Co-Founders

We looked at the whole charity landscape and met with all the charities. We didn’t feel that there was enough focus on funding transitional research. One thing we both felt strongly about was helping bridge ‘the valley of death’, the notorious time period in drug development where promising treatments languish in laboratories because researchers struggle to attract investment to get their research out of the laboratory and into early stage clinical trials.

We wanted to provide the investment that would create the bridge over that valley – and help bring promising treatments into the clinic. Our investments in Solid Biosciences, Reveragen and the development of Tamoxifen are all examples of this.